Skip to main content
logo
Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.70
+1.84 (8.42%)
Nov 6, 2026, 4:00 PM EST - Market closed

Damora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,467376202977
Market Cap Growth
18547.22%500.17%-68.63%-33.64%-61.57%-75.78%
Enterprise Value
94031-14-24-46-50
Last Close Price
23.7023.014.6518.0028.7575.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.010.150.390.600.480.65
P/TBV Ratio
4.01-0.420.600.480.65

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0000.010.010.010.01
Net Debt / Equity Ratio
-1.06-1.07-0.89-1.02-1.06-0.92
Net Debt / EBITDA Ratio
4.067.050.840.911.072.08
Net Debt / FCF Ratio
8.9238.290.760.891.512.06
Quick Ratio
14.7512.8812.585.985.5522.55
Current Ratio
14.8012.9814.076.315.7524.23
Return on Equity (ROE)
-115.80%-163.80%-89.03%-81.52%-68.86%-36.61%
Return on Assets (ROA)
-29.92%-16.46%-38.15%-40.90%-39.15%-22.22%
Return on Capital Employed (ROCE)
-26.20%-15.20%-106.00%-112.50%-98.60%-44.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-28.02%-570.92%-350.08%-196.45%-209.48%-67.61%
FCF Yield
-4.03%-18.30%-304.10%-189.08%-146.60%-68.63%
Buyback Yield / Dilution
-2895.78%-17.79%-8.87%-4.58%-0.58%-452.45%
SEC Filings: 10-K · 10-Q